Ezh2 loss is a haploinsufficient mediator of cell lineage in prostate cancer and has divergent effect on androgen receptor expression
Year: 2020
Type: conference-abstract
Source: The FASEB Journal
Institution: Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3016938543
